Arkansas Children's Hospital

REGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM AFFINITY DUCHENNE® TRIAL

Retrieved on: 
Tuesday, March 5, 2024
Jess, CK, Hospital, Duchenne muscular dystrophy, Arkansas Children's Hospital, Safety, Human, Immunosuppression, Patient, Phase, Ageing, Serum, Pharmaceutical industry

ROCKVILLE, Md., March 5, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today reported additional interim safety and efficacy data in the Phase I/II AFFINITY DUCHENNE® trial of RGX-202 in patients with Duchenne muscular dystrophy (Duchenne) ages 4 to11 years old, including RGX-202 microdystrophin expression from dose level 2 and video of trial clinic assessments demonstrating initial evidence of strength and functional improvement.

Key Points: 
  • ROCKVILLE, Md., March 5, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today reported additional interim safety and efficacy data in the Phase I/II AFFINITY DUCHENNE® trial of RGX-202 in patients with Duchenne muscular dystrophy (Duchenne) ages 4 to11 years old, including RGX-202 microdystrophin expression from dose level 2 and video of trial clinic assessments demonstrating initial evidence of strength and functional improvement.
  • "RGX-202 at dose level 2 is demonstrating significantly increased microdystrophin expression in a 12-year-old patient," said Kenneth T. Mills, President and CEO, REGENXBIO.
  • In addition, we are encouraged by the safety data at both dose levels and initial caregiver observations of strength and motor function improvement in boys treated with RGX-202.
  • "I am very pleased with the new microdystrophin expression data from RGX-202 dose level 2.

REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial

Retrieved on: 
Thursday, February 29, 2024
EST, Duchenne muscular dystrophy, Arkansas Children's Hospital, Conference, Interim, Webcast, Publication, Phase, PPMD, Episcopal conference, Pharmaceutical industry

Company to host webcast on Tuesday, March 5, 2024 at 8:30 a.m. EST

Key Points: 
  • Company to host webcast on Tuesday, March 5, 2024 at 8:30 a.m. EST
    Interim clinical data will be presented by Aravindhan Veerapandiyan, M.D., primary investigator of the AFFINITY DUCHENNE trial, at the MDA Clinical & Scientific Conference on Wednesday, March 6, 2024 at 12:00 p.m. EST
    ROCKVILLE, Md., Feb. 29, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a live webcast to discuss new interim clinical data from the Phase I/II AFFINITY DUCHENNE® trial of RGX-202 for the treatment of Duchenne muscular dystrophy.
  • Primary investigator Aravindhan Veerapandiyan, M.D.
  • Access: The live webcast can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com .
  • An archived replay of the webcast will be available for approximately 30 days following the presentation.

Arkansas Children's Establishes $70 Million Groundbreaking Center Focused on Opioids' Impact on Children

Retrieved on: 
Thursday, November 9, 2023
Arkansas Department of Health, Arkansas Children's Hospital, Brain, ESC, Research, Opioid, Fentanyl, NICU, Pediatrics, USDA, Substance abuse, Toxicology, Arkansas Department of Corrections, Learning, Informatics, History, Pregnancy, Journal, Map, Machine learning, Poisoning, Heroin, Health, Child, Birth, NCOR, School, Mother, Alcohol withdrawal syndrome, Social work, Hospital, The Journal of Pediatrics, Fetus, ROCK, Initiative, Face, Research institute, Pharmaceutical industry, Vaccine, Nursing, Birth control

LITTLE ROCK, Ark., Nov. 9, 2023 /PRNewswire/ -- Arkansas Attorney General Tim Griffin is awarding $50 million of opioid settlement funds to Arkansas Children's to pioneer one of the nation's most ambitious research efforts dedicated to opioids' impact on children.

Key Points: 
  • I am granting $50 million of the state's opioid settlement funds to help establish the National Center for Opioid Research & Clinical Effectiveness (NCOR) at Arkansas Children's.
  • "This research center will be the first of its kind not just in Arkansas, but in the entire country.
  • "By creating this center, we are accelerating a healthier future for the children of Arkansas.
  • Scientists will work closely with the Arkansas Children's Research Institute and Arkansas Children's Nutrition Center, one of six National Human Nutrition Centers funded through the USDA-ARS.

Davidson Hospitality Group Launches Inaugural "Davidson Day of Service" Companywide Initiative

Retrieved on: 
Wednesday, November 1, 2023
Civic, Mills House, Room, Arkansas Children's Hospital, Partnership, Hospital, Clothing, Autograph Collection, Mental health, Ethnic minorities in the U.S. Armed Forces during World War II, Workforce, Maintenance, Natural Resources, Police, Freestore Foodbank, Embassy Suites by Hilton, Homelessness, Heart, Jupiter, Conference, Convention center, Development, Mission Dolores Park, Cradles to Crayons, Woman, Gardening, Russia women's national volleyball team, The Mills House Hotel, ALR, Human, Davidson, Hilton Garden Inn: Ultimate Team Play, Jacobs, Margaritaville Resort Orlando, Community, Nutrition, Alexander, Hyatt, Tourism, Dredging, Restaurant, Hotel, Fast food, Crayon, Cartersville City School District

ATLANTA, Nov. 1, 2023 /PRNewswire/ -- Davidson Hospitality Group announces the inaugural launch of "Davidson Day of Service," a new companywide initiative aimed at giving back to the local communities at all 83 individual hotels and resorts within the portfolio, from coast to coast. From supporting food banks and assisting homeless shelters to contributing goods and equipment to local schools to trail clean-ups, each participating property has developed a thoughtful, meaningful engagement to make a positive impact on its community during the month of November.

Key Points: 
  • ATLANTA, Nov. 1, 2023 /PRNewswire/ -- Davidson Hospitality Group announces the inaugural launch of "Davidson Day of Service," a new companywide initiative aimed at giving back to the local communities at all 83 individual hotels and resorts within the portfolio, from coast to coast.
  • "Community service projects are not new to Davidson, as our company has been doing them for years.
  • I continue to be amazed by our team members for fortifying strong relationships with the communities in which we live and serve."
  • Davidson Hospitality Group corporate office will build care packages with school supplies for Peyton Forest Elementary in Atlanta, a Title 1, Part A school, which is economically and educationally disadvantaged.

PPMD Applauds FDA for Approval of AGAMREE® (Vamorolone) for Duchenne Patients Ages Two Years and Older

Retrieved on: 
Friday, October 27, 2023
Knowledge, FDA, Policy, Food, Arkansas Children's Hospital, Catalyst Pharmaceuticals, Research, Vamorolone, PPMD, Becker muscular dystrophy, Duchenne muscular dystrophy, Calvarial doughnut lesions-bone fragility syndrome, Insulin resistance, Patient, Hospital, Food and Drug Administration Amendments Act of 2007, Pharmaceutical industry, Becker, Duchenne

AGAMREE® marks a significant milestone as the second therapy approved for Duchenne that is applicable regardless of the specific genetic mutation.

Key Points: 
  • AGAMREE® marks a significant milestone as the second therapy approved for Duchenne that is applicable regardless of the specific genetic mutation.
  • Today's approval has the potential to offer patients a therapy option with better tolerability, addressing a significant unmet need in our community," said PPMD Founding President and CEO Pat Furlong.
  • We also want to commend FDA leadership for recognizing the potential of AGAMREE® to make a difference in the lives of individuals living with Duchenne," Furlong added.
  • "PPMD is pleased to have collaborated with other foundations and community partners to support the early development of vamorolone.

Arkansas Children's Looks Beyond the Diagnosis in Launch of Art Gallery Celebrating Children with Rare Diseases

Retrieved on: 
Friday, October 6, 2023
Diagnosis, Arkansas Children's Hospital, Organization, The, Heart, Medicine, Portrait, Education, ROCK, SS, Rare, Face, Chromosome, Dentistry

LITTLE ROCK, Ark., Oct. 6, 2023 /PRNewswire/ -- Children with rare diseases know a lot about some pretty grown-up topics. Many can tell you how doctors treat their life-altering symptoms while in pre-school. Others can recall lengthy therapy names before their first spelling test. Some can share statistics that prove just how unique they truly are while their peers are still learning to count.

Key Points: 
  • LITTLE ROCK, Ark., Oct. 6, 2023 /PRNewswire/ -- Children with rare diseases know a lot about some pretty grown-up topics.
  • Arkansas Children's , a leader in primary and specialty care, is teaming up with nonprofit Beyond the Diagnosis to make sure the beauty of childhood itself stays at the heart of the national conversation about rare diseases.
  • They are showcasing 40 artworks of children with rare diseases with Thea Foundation , an Arkansas non-profit that advocates for the importance of arts in education and development.
  • They are the first Arkansas children and Arkansas artists to be featured in the gallery.

Arkansas Children's Announces Largest Gift in System History

Retrieved on: 
Monday, August 7, 2023
Willard, Gastroenterology, Ear, Bed, Elective surgery, Eye, Tears, Health, ACH, Endoscopy, Fayetteville Public Library, Child, Nose, Operating, Hospital, Patient, Growth, PAT, NWA, Wellness, Truffle, Pharmaceutical industry, Hope, Arkansas Children's Hospital

SPRINGDALE, Ark., Aug. 7, 2023 /PRNewswire/ -- Arkansas Children's will further transform child health in northwest Arkansas through a $25 million investment from the Willard & Pat Walker Charitable Foundation, Inc. In recognition of this gift – the largest in Arkansas Children's history – the Arkansas Children's Northwest (ACNW) campus will be named the Pat Walker Campus. 

Key Points: 
  • In recognition of this gift – the largest in Arkansas Children's history – the Arkansas Children's Northwest (ACNW) campus will be named the Pat Walker Campus.
  • "Pat played such an integral role in making sure the children of Arkansas have every advantage they can have," said Macke.
  • This next step of where we're going with Arkansas Children's Northwest is part of our tribute."
  • In May, Arkansas Children's announced the expansion at its two hospitals as part of its commitment to make its highly specialized services more accessible for all Arkansas children, with an eye on Northwest Arkansas' accelerated growth.

Henry Repeating Arms Donates $200,000 to Pediatric Cancer Centers

Retrieved on: 
Thursday, May 18, 2023
Life, Face, Gun, Fred, Parent, Law enforcement, Finger, Cancer, U.S. News & World Report, Firearm, Organization, Hospital, Patient, Arkansas Children's Hospital, Child, Second Amendment to the United States Constitution, RICE, Nebraska Medicine, Health, News, Pharmaceutical industry

"If I could snap my fingers and resolve one thing in this world, without a doubt, it would be childhood cancer.

Key Points: 
  • "If I could snap my fingers and resolve one thing in this world, without a doubt, it would be childhood cancer.
  • It's impossible to imagine what these kids and their parents endure throughout treatment and beyond," said Anthony Imperato, Founder and CEO of Henry Repeating Arms.
  • Since June 2022, Henry Repeating Arms has donated over $1 million through its charitable branch called Guns for Great Causes to celebrate the company's 25th anniversary.
  • To learn more about Henry Repeating Arms and its products, visit henryusa.com .

New Guide: What Families Need to Know about Private, Public Charter, and Open Enrollment Education Options in the Arkansas LEARNS Act

Retrieved on: 
Tuesday, May 16, 2023
Parent, EFA, Research, Multimedia, Government, Apprenticeships, Skills, Children and Learning Act 2009, School, National School Choice Week, Arkansas Children's Hospital, National school, No Me Conoce, Success, Legislation, Tutoring, Nursing

MIAMI, May 16, 2023 /PRNewswire/ -- Starting in the 2023/24 school year, significant changes are arriving to Arkansas' K–12 school choice options, including open enrollment in traditional public schools, public charter school enrollment caps, and funding for families who want to enroll their children in private schools.

Key Points: 
  • This newly launched comprehensive resource answers most relevant questions and forecasts families' evolving options over the next three school years.
  • MIAMI, May 16, 2023 /PRNewswire/ -- Starting in the 2023/24 school year, significant changes are arriving to Arkansas' K–12 school choice options, including open enrollment in traditional public schools, public charter school enrollment caps, and funding for families who want to enroll their children in private schools.
  • In terms of scale, the biggest change involves Arkansas families' access to the new Educational Freedom Account Program, which was created by the Arkansas LEARNS Act.
  • More details about EFAs and the other types of schools impacted by the LEARNS Act can be found at schoolchoiceweek.com/arkansas-learns-act.

The National Kidney Foundation Honors Pediatric Nurse with Prestigious Carol Mattix Award

Retrieved on: 
Wednesday, March 29, 2023
Kidney failure, CDN, Clinic, Education, Peritoneal dialysis, National Kidney Foundation, Rachel Wammack, Research, Baptist Memorial Hospital, Dialysis, Kidney disease, Science, MSCE, Nephrology, Patient, NKF, Arkansas Children's Hospital, Council, RN, Hospital, Nursing, Health insurance, MD

NEW YORK, March 29, 2023 /PRNewswire/ -- In April, the National Kidney Foundation (NKF) will honor pediatric nurse Jeanetta Wammack , RN, CDN for her dedication as a Peritoneal Dialysis Nurse at Arkansas Children's Hospital by presenting her with the Council of Nephrology Nurses and Technicians award in the name of Carol Mattix.

Key Points: 
  • NEW YORK, March 29, 2023 /PRNewswire/ -- In April, the National Kidney Foundation (NKF) will honor pediatric nurse Jeanetta Wammack , RN, CDN for her dedication as a Peritoneal Dialysis Nurse at Arkansas Children's Hospital by presenting her with the Council of Nephrology Nurses and Technicians award in the name of Carol Mattix.
  • "Jeanetta's devotion to her patients would make Carol Mattix proud and truly continues her commitment to those facing kidney disease and kidney failure," said NKF President Sylvia Rosas, MD, MSCE.
  • In 1999, Wammack lost her father to end-stage kidney disease, which led her to become a dialysis nurse.
  • "I am honored, and in disbelief that the National Kidney Foundation would choose to honor me with the distinguished Carol Mattix Award," Jeanetta said.